Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Quantum Biopharma (QNTM) Receivables - Other (2019 - 2025)

Quantum Biopharma's Receivables - Other history spans 6 years, with the latest figure at $231053.0 for Q4 2025.

  • On a quarterly basis, Receivables - Other fell 38.33% to $231053.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $231053.0, a 38.33% decrease, with the full-year FY2025 number at $231053.0, down 38.33% from a year prior.
  • Receivables - Other hit $231053.0 in Q4 2025 for Quantum Biopharma, down from $2.9 million in the prior quarter.
  • Over the last five years, Receivables - Other for QNTM hit a ceiling of $7.4 million in Q1 2023 and a floor of $228764.0 in Q4 2023.
  • Historically, Receivables - Other has averaged $3.4 million across 4 years, with a median of $3.0 million in 2025.
  • Biggest five-year swings in Receivables - Other: soared 151.45% in 2023 and later crashed 59.07% in 2025.
  • Tracing QNTM's Receivables - Other over 4 years: stood at $374377.0 in 2022, then tumbled by 38.89% to $228764.0 in 2023, then skyrocketed by 63.78% to $374678.0 in 2024, then plummeted by 38.33% to $231053.0 in 2025.
  • Business Quant data shows Receivables - Other for QNTM at $231053.0 in Q4 2025, $2.9 million in Q3 2025, and $3.0 million in Q2 2025.